MediPal Holdings Corporation logo

MediPal Holdings Corporation

7459.T

JPXHealthcareMedical - Distribution

Latest quote

¥2,904.5

−¥13.50 · -0.46%

Aug 24, 2:37 PM JST

7459.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.

Industry
Medical - Distribution
Sector
Healthcare
Headquarters
JP
CEO
Shuichi Watanabe
Listed since
Jan 1, 2001
Employees
13,024

Market position

Volume
196.3K
0.47× average
Average volume
419.69K
Average daily volume
Market cap
594.44B JPY
Beta
-0.02
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
315.58B JPY
P/E (TTM)
12.78×
P/B (TTM)
0.91×
P/S (TTM)
0.15×
EV / EBITDA
2.87×
Earnings yield
7.03%
Free cash flow yield
6.60%
Dividend yield
2.27%

Profitability & efficiency

Gross margin
6.43%
Operating margin
1.36%
Net margin
1.21%
Return on equity
6.52%
Return on assets
2.21%
Return on invested capital
4.04%

Financial health

Debt / equity
0.07×
Current ratio
1.28×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends7%5%3%0%Gross margin, FY2022: 6.23%Gross margin, FY2023: 6.31%Gross margin, FY2024: 6.55%Gross margin, FY2025: 6.60%Gross margin, FY2026: 6.48%Operating margin, FY2022: 1.39%Operating margin, FY2023: 1.46%Operating margin, FY2024: 1.33%Operating margin, FY2025: 1.51%Operating margin, FY2026: 1.39%Net margin, FY2022: 0.89%Net margin, FY2023: 1.15%Net margin, FY2024: 1.17%Net margin, FY2025: 1.10%Net margin, FY2026: 1.11%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 6.23%. Gross margin FY2023 6.31%. Gross margin FY2024 6.55%. Gross margin FY2025 6.60%. Gross margin FY2026 6.48%. Operating margin FY2022 1.39%. Operating margin FY2023 1.46%. Operating margin FY2024 1.33%. Operating margin FY2025 1.51%. Operating margin FY2026 1.39%. Net margin FY2022 0.89%. Net margin FY2023 1.15%. Net margin FY2024 1.17%. Net margin FY2025 1.10%. Net margin FY2026 1.11%.

Income trends

Revenue

3.82T JPY+3.98%

Operating income

53.18B JPY-4.36%

Net income

42.54B JPY+5.60%
Income trends across reported periods4.2T JPY2.68T JPY1.17T JPY−349.37B JPYRevenue, FY2022: 3.29T JPYRevenue, FY2023: 3.36T JPYRevenue, FY2024: 3.56T JPYRevenue, FY2025: 3.67T JPYRevenue, FY2026: 3.82T JPYOperating income, FY2022: 45.63B JPYOperating income, FY2023: 48.97B JPYOperating income, FY2024: 47.33B JPYOperating income, FY2025: 55.61B JPYOperating income, FY2026: 53.18B JPYNet income, FY2022: 29.42B JPYNet income, FY2023: 38.81B JPYNet income, FY2024: 41.48B JPYNet income, FY2025: 40.28B JPYNet income, FY2026: 42.54B JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 3.29T JPY. Revenue FY2023 3.36T JPY. Revenue FY2024 3.56T JPY. Revenue FY2025 3.67T JPY. Revenue FY2026 3.82T JPY. Operating income FY2022 45.63B JPY. Operating income FY2023 48.97B JPY. Operating income FY2024 47.33B JPY. Operating income FY2025 55.61B JPY. Operating income FY2026 53.18B JPY. Net income FY2022 29.42B JPY. Net income FY2023 38.81B JPY. Net income FY2024 41.48B JPY. Net income FY2025 40.28B JPY. Net income FY2026 42.54B JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue3.82T JPY3.67T JPY3.56T JPY3.36T JPY3.29T JPY
Cost of goods sold3.57T JPY3.43T JPY3.33T JPY3.15T JPY3.09T JPY
Gross profit247.41B JPY242.25B JPY233.01B JPY212.12B JPY205.11B JPY
Research and development1.42B JPY991M JPY103M JPY108M JPY
Selling, general, and administrative194.22B JPY186.63B JPY185.68B JPY163.04B JPY159.38B JPY
Operating expenses194.22B JPY186.63B JPY185.68B JPY163.14B JPY159.49B JPY
Interest income234M JPY50M JPY29M JPY101M JPY177M JPY
Interest expense13M JPY7M JPY8M JPY34M JPY16M JPY
Depreciation and amortization28.19B JPY18.42B JPY17.98B JPY14.65B JPY14.34B JPY
Operating income53.18B JPY55.61B JPY47.33B JPY48.97B JPY45.63B JPY
Net income42.54B JPY40.28B JPY41.48B JPY38.81B JPY29.42B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
73%
8 beats, 3 misses, 0 met estimates
Average EPS surprise
+25.44%
11 comparable reports
Latest EPS result
66.66
Estimate 44.91 · Beat by 48.43%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates79.2957.6936.114.5Q1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 10, 2025: actual 69.72, estimate 37.64, surprise +85.23%, Beat. Q2 2025, reported May 13, 2025: actual 19.54, estimate 17.06, surprise +14.54%, Beat. Q3 2025, reported Aug 5, 2025: actual 46.17, estimate 46.24, surprise -0.15%, Miss. Q4 2025, reported Nov 5, 2025: actual 60.63, estimate 38.44, surprise +57.73%, Beat. Q1 2026, reported Feb 9, 2026: actual 74.68, estimate 50.37, surprise +48.26%, Beat. Q2 2026, reported May 14, 2026: actual 25.19, estimate 38.24, surprise -34.13%, Miss. Q3 2026, reported Aug 5, 2026: actual 66.66, estimate 44.91, surprise +48.43%, Beat. Q4 2026, reported Oct 29, 2026: actual —, estimate 60.63, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.05T975.48B896.3B817.11BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 10, 2025: actual 982.5B JPY, estimate 958.98B JPY, surprise +2.45%, Beat. Q2 2025, reported May 13, 2025: actual 864.16B JPY, estimate 857.68B JPY, surprise +0.76%, Beat. Q3 2025, reported Aug 5, 2025: actual 945.16B JPY, estimate 935.13B JPY, surprise +1.07%, Beat. Q4 2025, reported Nov 5, 2025: actual 952.4B JPY, estimate 939.61B JPY, surprise +1.36%, Beat. Q1 2026, reported Feb 9, 2026: actual 1.01T JPY, estimate 1.01T JPY, surprise +0.31%, Beat. Q2 2026, reported May 14, 2026: actual 905.69B JPY, estimate 892.1B JPY, surprise +1.52%, Beat. Q3 2026, reported Aug 5, 2026: actual 989.5B JPY, estimate 968.88B JPY, surprise +2.13%, Beat. Q4 2026, reported Oct 29, 2026: actual —, estimate 980.86B JPY, surprise —, Comparison unavailable.

7459.T peers

ETFs holding 7459.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 7459.T

research.disclaimer